A detailed history of Lazard Asset Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 5,499 shares of EW stock, worth $392,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,499
Previous 384,114 98.57%
Holding current value
$392,518
Previous $35.5 Million 98.98%
% of portfolio
0.0%
Previous 0.05%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $22.6 Million - $35.5 Million
-378,615 Reduced 98.57%
5,499 $362,000
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $24.5 Million - $27.4 Million
290,485 Added 310.25%
384,114 $35.5 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $3.21 Million - $4.23 Million
44,257 Added 89.64%
93,629 $8.95 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $11.8 Million - $14.8 Million
-190,763 Reduced 79.44%
49,372 $3.76 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $16.1 Million - $21.7 Million
-232,177 Reduced 49.16%
240,135 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $29.8 Million - $34.6 Million
366,597 Added 346.78%
472,312 $44.6 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $7.3 Million - $8.31 Million
98,360 Added 1337.32%
105,715 $8.75 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $19,124 - $24,483
-280 Reduced 3.67%
7,355 $548,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $3.57 Million - $4.64 Million
-43,281 Reduced 85.0%
7,635 $630,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $3.84 Million - $5.69 Million
44,390 Added 680.2%
50,916 $4.84 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $80,446 - $101,260
-789 Reduced 10.79%
6,526 $767,000
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $2.12 Million - $2.6 Million
-19,921 Reduced 73.14%
7,315 $947,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $2.16 Million - $2.58 Million
20,988 Added 335.92%
27,236 $3.08 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $314,819 - $393,373
-3,755 Reduced 37.54%
6,248 $646,000
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $40.8 Million - $47 Million
-518,554 Reduced 98.11%
10,003 $836,000
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $5.49 Million - $6.99 Million
-76,572 Reduced 12.65%
528,557 $48.2 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $3.7 Million - $4.82 Million
55,101 Added 10.02%
605,129 $48.3 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $24.6 Million - $32.9 Million
427,503 Added 348.91%
550,028 $38 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $305,655 - $472,392
5,832 Added 5.0%
122,525 $23.1 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $6.59 Million - $7.55 Million
91,949 Added 371.6%
116,693 $27.2 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $342,402 - $419,617
5,563 Added 29.0%
24,744 $5.44 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $230,429 - $266,270
-4,134 Reduced 17.73%
19,181 $3.54 Million
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $253,673 - $339,272
5,297 Added 29.4%
23,315 $4.46 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $1.21 Million - $1.48 Million
-26,066 Reduced 59.13%
18,018 $2.76 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $18,325 - $23,270
-401 Reduced 0.9%
44,084 $7.67 Million
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $1.46 Million - $1.77 Million
34,455 Added 343.52%
44,485 $6.48 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $372,346 - $475,069
10,012 Added 55622.22%
10,030 $1.4 Million
Q3 2017

Nov 13, 2017

SELL
$36.29 - $38.83 $64,160 - $68,651
-1,768 Reduced 98.99%
18 $1,000
Q2 2017

Aug 19, 2019

SELL
N/A
-7,719 Reduced 81.21%
1,786 $211,000
Q1 2017

Aug 13, 2019

SELL
N/A
-5,779 Reduced 37.81%
9,505 $894,000
Q3 2015

Jul 15, 2019

SELL
N/A
-21,330 Reduced 58.26%
15,284 $2.17 Million
Q2 2015

Jul 08, 2019

SELL
N/A
-42,120 Reduced 53.5%
36,614 $5.21 Million
Q4 2014

Aug 29, 2019

BUY
N/A
78,734
78,734 $10 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.